Littleton, CO (PRWEB) February 25, 2016
CereScan, the nation’s leader in providing statistically measured brain diagnostics, has been selected as one of the top 60 social ventures for the 2016 CO Impact Days and Initiative Showcase on March 4, 2016. The functional brain imaging and analytics company was chosen from more than 280 Colorado applicants to participate in the first of its kind, statewide marketplace for impact investing.
CereScan is a brain science and analytics company that includes what is believed to be the country’s largest and most complete functional brain imaging data warehouse. The CereMetrixTM database will unite the Company’s brain imaging with vital medical data to give practitioners access to the information needed to make better, faster diagnostic decisions for complex brain conditions.
CereScan, along with the other chosen ventures, will convene at the Ellie Caulkins Opera House at the Denver Center for the Performing Arts (DCPA) to meet face to face with accredited investors in order to seek millions of dollars of impact investments. The chosen social ventures will have the opportunity to showcase their ability to provide a return on the impact investor's investment, while improving Colorado communities, to more than 200 accredited investors.
“This is the first time in the U.S. that 200 accredited impact investors will come together for a statewide marketplace, where they can connect with each other, learn, and have intimate access to social ventures representing projects, for profits, nonprofits, and funds at any stage of growth,” said Dr. Stephanie Gripne, Founder of the Impact Finance Center and creator of CO Impact Days and Initiative. “This is a first for impact investors and social ventures.”
The goal of CO Impact Initiative is to catalyze $100 million in impact investments into Colorado social ventures in the next three years, and it is kicking off with CO Impact Days on March 2-4. CO Impact Days encourages a new breed of impact investors and community members to Learn. Connect. Invest.
“The name of the gathering says it all,” said CereScan Chair and CEO, John Kelley. “CO Impact Days provides a unique platform for CereScan and similar socially conscious organizations to effectively connect with potential financial resources within our realm. Our success will undoubtedly have an impact on a local and a national scale in the area of brain diagnostics and clinical research into brain disorders.”
CO Impact Days’ innovation is uniquely possible because Colorado is home to a number of national leaders in impact investing and a thriving and collaborative community of social venture entrepreneurs in both the for profit and nonprofit sectors, philanthropists and investors who are committed to growing Colorado’s economy and creating valuable jobs while ensuring our state remains one of the best places to work, live, and play in the U.S.
Voting for the People’s Choice Award will close on Monday, February 29 at 5p.m. The company with the most votes will receive the Award on Friday, March 4th, which will include a five-minute presentation on the stage of the Ellie Caulkins Opera House! To advocate on behalf of CereScan, please cast your vote at http://woobox.com/qh6kj7/gallery/j2Lhh19DHGU (no sign-up required).
Among the more than 200 accredited impact investors, foundations, and family offices participating in CO Impact Days and Initiative are Gary Community Investments, Colorado Health Foundation, The Denver Foundation and Innovest Portfolio Solutions, along with Linda Appel Lipsius, Andrew C. Currie, Rich Hoops, Jim and Melanie Davidson, and Jenn Vervier.
CereScan combines state-of-the-art SPECT and PET/CT brain imaging technologies with a patient centered model of care to provide the highest level of neurodiagnostics anywhere. Using quantitative functional brain imaging, advanced imaging software, and an extensive library of clinical data, the CereScan medical team provides physicians with unmatched objective diagnostic information. CereScan helps patients and their physicians better understand the neurological basis of their conditions. In a variety of legal settings, CereScan provides objective evidence to attorneys and their clients regarding traumatic and toxic brain injuries. For researchers, CereScan provides independent pre- and post-treatment measures of organic changes in the brain along with measures of symptoms related to the brain disorder of interest. For more information, please call (866) 722-4806 or visit http://www.CereScan.com.
About CO Impact Days and Initiative
CO Impact Days is the first of its kind effort to create a statewide marketplace for impact investing; identifying, connecting, and celebrating Colorado's top social ventures and impact investors from the Western Slope to the Front Range. CO Impact Days’ will to bring together Colorado’s top 60 social ventures, 200 impact investors, and 500+ community members to Learn. Connect. Invest. For more information or tickets, visit http://www.coimpactdays.org or contact Molly at email@example.com.
CO Impact Initiative, created by the Impact Finance Center and led by Dr. Stephanie Gripne and a steering committee of community leaders is a 3-year strategy to elevate and accelerate impact investing in Colorado, catalyzing the flow of $100 million in investment capital into Colorado social ventures that deliver positive impact on the state’s communities, economy and natural environment.